Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Livzon Fuzhou Fuxing Pharmaceutical is a major Chinese pharmaceutical manufacturer and a core subsidiary of the Livzon Pharmaceutical Group. Established in 1979 and headquartered in Fuzhou, the company is a global leader in the production of fermentation-based active pharmaceutical ingredients (APIs), particularly antibiotics. Its key products include Vancomycin, Teicoplanin, and Colistin Sulfate, which are exported to over 30 countries and regions. The company operates large-scale, GMP-compliant facilities that integrate R&D, fermentation, and chemical synthesis. As a vital component of Livzon's industrial chain, Fuzhou Fuxing supports the group's dominance in the anti-infective and gastrointestinal therapeutic sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Livzon Group Fuzhou Fuxing Pharmaceutical.